Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05922800Unknown
Randomised, open-label trial (2 arms), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoint: Proportion of patients with a reduction of 50% or more on the mean 24-hour HF score at 6 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05922800.